Activities per year
Activities
- 25 results
Search results
-
Navigating new regulations in biobanking for clinical studies and research projects
Jonathan Douxfils (Speaker)
4 Oct 2023Activity: Talk or presentation types › Oral presentation
-
Fantastic 4 - E4stetrol in Women's Health
Jonathan Douxfils (Invited speaker) & Jean-Michel Foidart (Invited speaker)
4 May 2023 → 6 May 2023Activity: Talk or presentation types › Oral presentation
-
Acquired APC resistance as a marker for VTE, how does the estrogens differ?
Jonathan Douxfils (Invited speaker)
24 Mar 2023Activity: Talk or presentation types › Oral presentation
-
Description of chalcogen interactions in smoothed Cromer-Mann electron density distributions
Laurence Leherte (Speaker)
19 Jul 2022Activity: Talk or presentation types › Oral presentation
-
Study of Drug-Protein non-Covalent Interactions from Smoothed Electron Density Distributions
Laurence LEHERTE (Speaker)
18 Aug 2021Activity: Talk or presentation types › Oral presentation
-
Affections thromboemboliques veineuses – partie II
Jonathan Douxfils (Keynote speaker)
12 Mar 2019Activity: Talk or presentation types › Oral presentation
-
Mécanismes thrombotiques des inhibiteurs de tyrosine kinase ciblant BCR-ABL
Hélène Haguet (Speaker), Jonathan Douxfils (Speaker), François Mullier (Speaker), Christian Chatelain (Speaker), Carlos Graux (Speaker) & Jean-Michel Dogne (Speaker)
21 Mar 2019Activity: Talk or presentation types › Oral presentation
-
Nanoparticules dans les peintures : quels risques pour la santé?
Julie Laloy (Speaker)
23 Mar 2018Activity: Talk or presentation types › Oral presentation
-
Spin-off et financement - Présentation de QUALIblood
Damien Gheldof (Speaker) & Jonathan Douxfils (Speaker)
6 Mar 2018Activity: Talk or presentation types › Oral presentation
-
DOACs: new test on development
Jonathan Douxfils (Speaker)
2 Mar 2018Activity: Talk or presentation types › Oral presentation
-
Influence of Protein-Solvent Interactions on the Molecular Dynamics of Reduced Point Charge Models of Proteins - COMP5
Laurence Leherte (Speaker) & Daniel Vercauteren (Speaker)
18 Mar 2018Activity: Talk or presentation types › Oral presentation
-
In vitro effects of BCR-ABL TKIs on endothelial cell survival and functions
Hélène Haguet (Speaker), Jonathan Douxfils (Speaker), Christian Chatelain (Speaker), Carlos Graux (Speaker), François Mullier (Speaker) & Jean-Michel Dogne (Speaker)
9 Feb 2018Activity: Talk or presentation types › Oral presentation
-
Nanoparticules dans les peintures: quels risques pour la santé?
Julie Laloy (Speaker)
2018Activity: Talk or presentation types › Oral presentation
-
Reduced point charge models of proteins - Influence of protein-solvent interactions
Laurence Leherte (Speaker)
28 Aug 2017Activity: Talk or presentation types › Oral presentation
-
Assessment of thrombin generation in plasma samples of patients under anticoagulant treatment with ST Genesia system using STG – DrugScreen
Jonathan Douxfils (Speaker)
29 Jun 2017Activity: Talk or presentation types › Oral presentation
-
Risk of vascular occlusive events with BCR-ABL TKIs in CML
Hélène Haguet (Speaker), Jonathan Douxfils (Speaker), François Mullier (Speaker), Christian Chatelain (Speaker), Carlos Graux (Speaker) & Jean-Michel Dogne (Speaker)
25 Feb 2017Activity: Talk or presentation types › Oral presentation
-
Applications and prospects in multiresolution analyses of molecular structures and properties
Laurence Leherte (Speaker)
31 Jan 2017Activity: Talk or presentation types › Oral presentation
-
Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis
Hélène Haguet (Speaker), Jonathan Douxfils (Speaker), François Mullier (Speaker), Christian Chatelain (Speaker), Carlos Graux (Speaker) & Jean-Michel Dogne (Speaker)
28 Apr 2016Activity: Talk or presentation types › Oral presentation
-
Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis
Hélène Haguet (Speaker), Jonathan Douxfils (Speaker), François Mullier (Speaker), Christian Chatelain (Speaker), Carlos Graux (Speaker) & Jean-Michel Dogne (Speaker)
29 Jan 2016Activity: Talk or presentation types › Oral presentation
-
Risk of cardiovascular events associated with BCR-ABL TKI in leukemic population: a systematic review and meta-analysis
Jonathan Douxfils (Speaker), Hélène Haguet (Speaker), François Mullier (Speaker), Christian Chatelain (Speaker), Carlos Graux (Speaker) & Jean-Michel Dogne (Speaker)
Jun 2015Activity: Talk or presentation types › Oral presentation
-
Hemocompatibility of nanoparticles: impact on fibrinolysis.
Julie Laloy (Speaker)
2014Activity: Talk or presentation types › Oral presentation
-
Effect of dabigatran etexilate on the risk of myocardial infarction and other cardiac events: A systematic review and updated dose-response meta-analysis of randomized controlled trials
Jonathan Douxfils (Speaker)
1 Jul 2013Activity: Talk or presentation types › Oral presentation
-
Hemocompatibility of manufactured nanoparticles: Guidelines proposal.
Julie Laloy (Speaker)
2013Activity: Talk or presentation types › Oral presentation
-
Impact of nanomaterials on human health: Strategies of the Namur Nanosafety Center (NNC).
Julie Laloy (Speaker)
2012Activity: Talk or presentation types › Oral presentation
-
Assessment of different methods studying the impact of carbon nanomaterials on platelet function.
Julie Laloy (Speaker)
2012Activity: Talk or presentation types › Oral presentation